PERSPECTA

News from every angle

← Back to headlines

Fulgent Outlines $350 Million 2026 Revenue Outlook Post-Acquisition

Fulgent Genetics projected a $350 million revenue outlook for 2026 following its acquisition of Bako/StrataDx.

1 May, 16:23 — 1 May, 16:23
PostShare

Sources

Showing 1 of 1 sources
seeking-alphaMixed126d ago

Fulgent outlines $350M 2026 revenue outlook following Bako/StrataDx acquisition

Read full article →

Related Stories

Stock Markets Drop Following Strong U.S. Jobs Report

39m ago

Japan and U.S. Advance $550 Billion Investment Pact Focused on AI and Chips

1h ago

Anthropic Delays AI Startup IPO to Mid-October Amid Credit Facility Deal

2h ago

Trade Negotiations Stall as U.S. Halts Antitrust Cooperation With Canada

2h ago